Loading organizations...
§ Venture Capital · Boston, MA, USA
Vectis Healthcare & Life Sciences Fund operates as an investment vehicle specializing in fund investments and direct co-investments across the healthcare and life sciences sectors. The fund strategically allocates capital into innovative companies and other investment funds that are dedicated to advancing medical and scientific breakthroughs. Its approach often involves supporting ventures focused on developing novel solutions for pressing health challenges.
The fund's origins trace back to its initial vehicle, Vectis Life Sciences Fund I, a 2004 vintage fund co-managed by BPEA Private Equity, also known as Brooke Private Equity Advisors Management. The foundational insight behind its creation was to catalyze growth within life science startups, with an early emphasis on fostering entrepreneurship and development in regions such as St. Louis, Missouri. This established its commitment to early-stage scientific innovation.
Vectis Healthcare & Life Sciences Fund primarily backs companies that are developing compelling solutions for unmet healthcare needs, including those in biotechnology and pharmaceuticals. The fund aims to drive progress by providing essential capital and strategic support to these entities. Its long-term vision centers on fostering significant advancements within the healthcare and life sciences ecosystems, ultimately contributing to improved patient outcomes and industry innovation.
Vectis Healthcare and Life Sciences Fund has 2 tracked investments across 2 companies. The latest tracked deal is $45.0M Series D in Proteon Therapeutics in May 2014.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 16, 2014 | Proteon Therapeutics | $45.0M Series D | TIM Haines | Bessemer Venture Partners, Deerfield Management, Devon Park Bioventures, Intersouth Partners, MPM Capital, Dmitry Kobyzev, Ph.d., Prism VentureWorks, Skyline Ventures, TVM Capital |
| Jul 1, 2010 | EndoStim | $6.0M Series B | Santé Ventures | Prolog Ventures |